Your session is about to expire
← Back to Search
Chemoradiation + Radiation Boost for Rectal Cancer (Morpheus Trial)
Morpheus Trial Summary
This trial is studying two different types of radiation therapy for rectal cancer.
Morpheus Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMorpheus Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Morpheus Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
Is this study only recruiting patients who are 45 years or older?
"This particular trial is meant for patients aged 18 to 80. However, there are 11 other trials for patients who are underage and 315 trials for patients that are elderly."
Who meets the screening requirements for this particular research study?
"This study is looking for 145 individuals over the age of 18 who have rectal carcinoma. The most crucial inclusion criteria are as follows: The tumor cannot be located more than 10 cm away from the anal verge, the rectal cancer must be clinically staged as a T2 or T3 by MRI or endoscopic/trans-rectal ultrasound, the rectal cancer must be staged as an N0 by MRI or EUS/TRUS, there cannot be any metastatic lesions, the rectal tumor cannot occupy more than half the circumference, the tumor cannot be larger than 5 cm on its largest dimension, the tumor penetration in the"
What are the benefits that patients might experience from participating in this clinical trial?
"The primary endpoint for this study will be TME-free survival rates two years after treatment. Additionally, the research team will also be measuring for overall survival, local recurrence, and changes in quality of life over time."
Share this study with friends
Copy Link
Messenger